Lhrh antagonists and intermediate products

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 7/23 (2006.01) A61K 38/09 (2006.01) C07D 295/15 (2006.01) C07D 521/00 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2109830

The invention concerns LHRH antagonists of the general formula (I), in which X is an acyl group, X1 is a D-Nal, X2 is D-(4-C1)-Phe, X3 is D-(3)-Pal, X6 is D-Cit or D-Neu, X8 is L-Arg or L-Neu, at least one of the groups X6 and X8 being a Neu, and X10 is D-Ala-NH2, Neu being a group formulae (II), (III) or (IV), wherein W is one of the group (a), (b), (c), or (d). The invention includes drugs containing a compound of formula (I), plus the usual auxiliaries and carriers. These drugs are suitable for use in cases of carcinoma of the prostate and in endometriosis, as well as for fertility control.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Lhrh antagonists and intermediate products does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lhrh antagonists and intermediate products, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lhrh antagonists and intermediate products will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1740280

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.